ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Neuroprotection by canagliflozin in a Huntington's disease model: role of HIF-1α and PI3K/AKT signaling.

Ali M Elgindy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.